Journal List > J Korean Ophthalmol Soc > v.56(12) > 1010174

Koh and Kim: Clinical Features of Patients Complaining of Visual Symptoms and Diagnosed with Migraine

Abstract

Purpose

To describe the characteristics of patients who visited Korean ophthalmology clinics complaining of visual symptoms and were diagnosed with migraine.

Methods

A retrospective study was performed by evaluating the patterns of visual symptoms, timing of headaches, and results of ophthalmologic examinations in 31 migraine patients who were recruited from a neuro-ophthalmology clinic.

Results

The patients consisted of 9 men and 22 women, with a mean age of 38.1 years (range, 12-71). The average age of symptom onset was 35.7 years (range, 12-64 years). The most common three visual symptoms were blurred vision (35.5%), blind spots (22.6%), and flashes of bright lights (22.6%). Visual symptoms disappeared within 5 minutes in 16 patients (51.6%) and 13 patients (41.9%) experienced visual symptoms before the onset of a headache. Brain magnetic resonance imaging find-ings in 14 cases revealed normal results and the remaining three patients showed minimal small vessel disease. Except for one patient who had exotropia, there was no other specific abnormality observed upon ophthalmologic examinations.

Conclusions

Most of the migraine patients who first visited an ophthalmology clinic with visual symptoms had no definite ocular abnormalities. Thus, ophthalmologists must be aware that migraines could first present with various visual symptoms in order to make an early diagnosis of migraine.

References

1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33:629–808.
2. Vos T, Flaxman AD, Naghavi M. . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380:2163–96.
3. Queiroz LP, Friedman DI, Rapoport AM, Purdy RA. Characteristics of migraine visual aura in Southern Brazil and Northern USA. Cephalalgia. 2011; 31:1652–8.
crossref
4. Jeon HS, Lee KH, Choi DG. Clinical characteristics of children di-agnosed with migraine. J Korean Ophthalmol Soc. 2012; 53:1500–4.
crossref
5. Hong JT, Lim HT. A case of prolonged bilateral inferior altitudinal visual field defect in a young migraineur. J Korean Ophthalmol Soc. 2010; 51:1537–42.
crossref
6. Choi JH, Lee JY, Kim YJ. Three cases of ophthalomplegic migraine. J Korean Ophthalmol Soc. 2010; 51:307–11.
crossref
7. Yoon KC, Mun GH, Kim SD. . Prevalence of eye diseases in South Korea: data from the Korea national health and nutrition ex-amination survey 2008-2009. Korean J Ophthalmol. 2011; 25:421–33.
crossref
8. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia. 2004; 24:728–34.
crossref
9. Viticchi G, Bartolini M, Falsetti L. . Diagnostic delay in mi-graine with aura. Neurol Sci. 2013; 34:Suppl 1. S141–2.
crossref
10. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996; 119:(Pt 2). 355–61.
crossref
11. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995; 24:612–8.
crossref
12. Aiba S, Tatsumoto M, Saisu A. . Prevalence of typical migraine aura without headache in Japanese ophthalmology clinics. Cephalalgia. 2010; 30:962–7.
crossref
13. Queiroz LP, Rapoport AM, Weeks RE. . Characteristics of mi-graine visual aura. Headache. 1997; 37:137–41.
crossref
14. Fleming JB, Amos AJ, Desmond RA. Migraine aura without head-ache: prevalence and risk factors in a primary eye care population. Optometry. 2000; 71:381–9.
15. Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. ‘Visual snow’ - a disorder distinct from persistent migraine aura. Brain. 2014; 137:(Pt 5). 1419–28.
crossref
16. Schankin CJ, Maniyar FH, Sprenger T. . The relation between migraine, typical migraine aura and “visual snow”. Headache. 2014; 54:957–66.
crossref
17. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006; 295:1824–30.
18. Shyti R, de Vries B, van den Maagdenberg A. Migraine genes and the relation to gender. Headache. 2011; 51:880–90.
crossref
19. Schürks M, Buring JE, Kurth T. Migraine features, associated symptoms and triggers: a principal component analysis in the Women’s Health Study. Cephalalgia. 2011; 31:861–9.
crossref
20. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci. 2000; 41:1239–47.

Table 1.
ICHD-3 classification of migraine
ICHD-3 code Diagnosis
1.1 Migraine without aura
1.2 Migraine with aura
1.2.1 Migraine with typical aura
1.2.1.1 Typical aura with headache
1.2.1.2 Typical aura without headache
1.2.2 Migraine with brainstem aura
1.2.3 Hemiplegic migraine
1.2.4 Retinal migraine
1.3 Chronic migraine
1.4 Complications of migraine
1.5 Probable migraine
1.6 Episodic syndromes that may be associated with migraine

ICHD = the International Classification of Headache Disorders.

Table 2.
Baseline characteristics of patients (n = 31)
Demographic data Data
Sex (n, %)
Male 9 (29.0)
Female 22 (71.0)
Age (years, range) 38.1 ± 16.0 (12-71)
Age at onset of visual symptom 35.7 ± 13.9 (12-64)
(years, range)
Values are presented as mean ± SD unless otherwise indicated. n = number of patients.
Table 3.
Distribution of patients according to visual symptoms (n = 31)
Characteristics of visual symptoms n %
Blurred vision 11 35.5
Blind spots 7 22.6
Flashes of bright light 7 22.6
Flickering lights 3 9.7
White spots 1 3.2
Small bright dots like stars 1 3.2
Curved forms 1 3.2
Laterality
Bilateral 22 71.0
Unilateral 9 29.0
Table 4.
Timing of visual symptoms (n = 31)
Timing of attack n %
Timing of visual symptoms
Before the headaches 13 41.9
At the same time with the headaches 6 19.4
Do not know 2 6.5
No headaches 10 32.3
Duration of visual symptoms
<5 minutes 16 51.6
5 to 30 minutes 7 22.3
31 to 60 minutes 6 19.4
>60 minutes 2 6.5
Table 5.
Results of ophthalmologic examination (n = 31)
Ophthalmic examination Data
BCVA (log MAR)
OD 0.009 ± 0.23
OS 0.005 ± 0.15
IOP (mm Hg)
OD 14.44 ± 3.35
OS 15.00 ± 3.69
Ocular motility (n, %)
Orthotropia 30 (96.8)
Exotropia 1 (3.2)
Refractive error (n, %)
Emmetropia 9 (29.0)
Myopia 21 (67.7)
Hypertropia 1 (3.2)

Values are presented as mean ± SD unless otherwise indicated. BCVA = best corrected visual acuity; log MAR = logarithm of the minimum angle of resolution; OD = oculus dexter; OS = oculus sinister; IOP = intraocular pressure.

Table 6.
Results of MRI and EEG
Neurologic study Data
MRI (n = 17, %)
Normal 14 (82.4)
Focal cerebral vascular disease 3 (17.6)
EEG (n = 4, %)
Normal 4 (100)

MRI = magnetic resonance imaging; EEG = electroencephalogram.

TOOLS
Similar articles